Glanzmann thrombasthenia: a model disease which paved the way to powerful therapeutic agents

Publisher： Karger

E-ISSN： 1424-8840|32|5-6|216-217

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.5-6, 2003-08, pp. : 216-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Glanzmann's thrombasthenia: meeting the anticoagulation challenge

By  

HAEMOPHILIA, Vol. 21, Iss. 4, 2015-07 ,pp. : e322-e323

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel Mutations in the GPIIb and GPIIIa Genes in Glanzmann Thrombasthenia

By  

Transfusion Medicine and Hemotherapy, Vol. 37, Iss. 5, 2010-09 ,pp. : 268-277

Karger

Access to resources Recommend Favorite

New therapeutic agents for diabetic kidney disease

By Agrawal Varun   Kizilbash Sani Haider   McCullough Peter A  

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 553-575

Future Medicine

Access to resources Recommend Favorite

Giant Abdominopelvic Haematoma Arising from Ovulation in a Glanzmann’s Thrombasthenia Patient with Platelet Refractoriness: Treatment with Surgery and Intra-Abdominal Tranexamic Acid

By  

Acta Haematologica, Vol. 128, Iss. 3, 2012-08 ,pp. : 154-157

Karger

Access to resources Recommend Favorite

Therapeutic Treatment of Alzheimer's Disease Using Metal Complexing Agents

By  

Recent Patents on CNS Drug Discovery, Vol. 2, Iss. 3, 2007-11 ,pp. : 180-187

Bentham Science Publishers

Access to resources Recommend Favorite